Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4262611000168116 | Irinotecan (WKT) (irinotecan hydrochloride trihydrate 300 mg / 15 mL) injection, 1 x 15 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4262621000168111 | Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | Is a | irinotecan hydrochloride trihydrate 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | ||
Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | has TP | Irinotecan (WKT) | true | Inferred relationship | Some | ||
Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | has TPUU | Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 975542626 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | Is a | True | Irinotecan (WKT) 300 mg/15 mL injection, 15 mL vial | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Trade product pack reference set